Clinical Trial Update: A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab plus bevacizumab to active surveillance as adjuvant therapy in high-risk hepatocellular carcinoma after resection or ablati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2023-11-18